NEW YORK (GenomeWeb) – Interleukin Genetics today reported that its first quarter revenues fell 17 percent year over year on lower genetic testing service revenue.

The Waltham, Massachusetts-based genetic testing firm reported total revenues of $403,212 for the three months ended March 31 compared to $487,566 for the first quarter of 2014. Its genetic testing service revenue declined to $347,900 from $420,333 year over year, which the firm attributed to a decrease in genetic test kits returned for processing from a promotional product bundle program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.